Literature DB >> 25955814

Symptomatic versus Asymptomatic Intervertebral Disc Degeneration: Is Inflammation the Key?

Yan Peng1, Feng-Juan Lv2.   

Abstract

Degenerated intervertebral discs (d-IVDs) contribute to low back pain (LBP) and are highly common. While some d-IVDs cause discogenic LBP, others are pain-free. Understanding the differences in pathophysiology between painful and pain-free intervertebral disc degeneration (IDD), especially the pathogenic signaling involved in the regulation of painful d-IVDs, is vital for achieving satisfactory effects in clinical treatment. In this review, we revisit recent findings on the detection of inflammatory factors in d-IVDs and summarize the differences between d-IVDs that are painful and those that are pain-free. We postulate that persistent inflammation and innervation are the key factors distinguishing those that are symptomatic and those that are not. This highlights the necessity to use painful, rather than pain-free, degenerated discs in the mechanistic study of disc degeneration and in the development of regenerative approaches, to avoid false positive/negative outcomes. Based on previous molecular d-IVD studies, we also postulate the signaling events from disc overload/ injury to discogenic pain. Although these proposed events are supported by experimental findings, many details about how they are interconnected are not addressed and therefore require experimental investigation.

Entities:  

Mesh:

Year:  2015        PMID: 25955814     DOI: 10.1615/critreveukaryotgeneexpr.2015012369

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  12 in total

1.  NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration.

Authors:  Juliane D Glaeser; Khosrowdad Salehi; Linda E A Kanim; Zachary NaPier; Michael A Kropf; Jason M Cuéllar; Tiffany G Perry; Hyun W Bae; Dmitriy Sheyn
Journal:  Spine J       Date:  2020-05-12       Impact factor: 4.166

2.  IL-17 mediates inflammatory reactions via p38/c-Fos and JNK/c-Jun activation in an AP-1-dependent manner in human nucleus pulposus cells.

Authors:  Jing-kun Li; Lin Nie; Yun-peng Zhao; Yuan-qiang Zhang; Xiaoqing Wang; Shuai-shuai Wang; Yi Liu; Hua Zhao; Lei Cheng
Journal:  J Transl Med       Date:  2016-03-17       Impact factor: 5.531

3.  Single Nucleotide Variants of Candidate Genes in Aggrecan Metabolic Pathway Are Associated with Lumbar Disc Degeneration and Modic Changes.

Authors:  Romain Shanil Perera; Poruwalage Harsha Dissanayake; Upul Senarath; Lalith Sirimevan Wijayaratne; Aranjan Lional Karunanayake; Vajira Harshadeva Weerabaddana Dissanayake
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

4.  Obesity Mediates Apoptosis and Extracellular Matrix Metabolic Imbalances via MAPK Pathway Activation in Intervertebral Disk Degeneration.

Authors:  Xuyang Zhang; Jian Chen; Bao Huang; Jiasheng Wang; Zhi Shan; Junhui Liu; Yilei Chen; Shengyun Li; Shunwu Fan; Fengdong Zhao
Journal:  Front Physiol       Date:  2019-10-10       Impact factor: 4.566

Review 5.  Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions.

Authors:  Feng-Juan Lyu; Haowen Cui; Hehai Pan; Kenneth Mc Cheung; Xu Cao; James C Iatridis; Zhaomin Zheng
Journal:  Bone Res       Date:  2021-01-29       Impact factor: 13.567

6.  CGRP Regulates Nucleus Pulposus Cell Apoptosis and Inflammation via the MAPK/NF-κB Signaling Pathways during Intervertebral Disc Degeneration.

Authors:  Kaiqiang Sun; Jian Zhu; Chen Yan; Fudong Li; Fanqi Kong; Jingchuan Sun; Xiaofei Sun; Jiangang Shi; Yuan Wang
Journal:  Oxid Med Cell Longev       Date:  2021-12-26       Impact factor: 6.543

7.  The Upregulation of COX2 in Human Degenerated Nucleus Pulposus: The Association of Inflammation with Intervertebral Disc Degeneration.

Authors:  Chang Liu; Guoyan Liang; Zhantao Deng; Jing Tan; Qiujian Zheng; Feng-Juan Lyu
Journal:  Mediators Inflamm       Date:  2021-10-18       Impact factor: 4.711

Review 8.  The involvement of immune system in intervertebral disc herniation and degeneration.

Authors:  Fubiao Ye; Feng-Juan Lyu; Hua Wang; Zhaomin Zheng
Journal:  JOR Spine       Date:  2022-03-15

Review 9.  Should Degenerated Intervertebral Discs of Patients with Modic Type 1 Changes Be Treated with Mesenchymal Stem Cells?

Authors:  Nick Herger; Paola Bermudez-Lekerika; Mazda Farshad; Christoph E Albers; Oliver Distler; Benjamin Gantenbein; Stefan Dudli
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 10.  IVD progenitor cells: a new horizon for understanding disc homeostasis and repair.

Authors:  Feng-Juan Lyu; Kenneth M Cheung; Zhaomin Zheng; Hua Wang; Daisuke Sakai; Victor Y Leung
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.